European Commission Approves Symtuza ® for the Treatment of HIV-1 In Adults and Adolescents in Europe

- Symtuza ® is the only darunavir-based single-tablet regimen (STR) approved for the treatment of HIV-1 in the European Union
Source: Johnson and Johnson - Category: Pharmaceuticals Source Type: news